Johanna A. van der Zande

ORCID: 0000-0002-9569-6551
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiovascular Issues in Pregnancy
  • Maternal Mental Health During Pregnancy and Postpartum
  • Cardiac Arrhythmias and Treatments
  • Cardiac Structural Anomalies and Repair
  • Pregnancy and preeclampsia studies
  • Cardiac, Anesthesia and Surgical Outcomes
  • Pulmonary Hypertension Research and Treatments
  • Uterine Myomas and Treatments
  • Reproductive Health and Contraception
  • Family and Patient Care in Intensive Care Units
  • Pregnancy and Medication Impact
  • Mechanical Circulatory Support Devices
  • Ovarian cancer diagnosis and treatment
  • Maternal and fetal healthcare
  • Menopause: Health Impacts and Treatments
  • Hemodynamic Monitoring and Therapy
  • Trauma Management and Diagnosis
  • Moyamoya disease diagnosis and treatment
  • Pharmaceutical studies and practices
  • Congenital Heart Disease Studies
  • Intensive Care Unit Cognitive Disorders
  • Estrogen and related hormone effects
  • Aortic Disease and Treatment Approaches
  • Endometrial and Cervical Cancer Treatments
  • Ultrasound in Clinical Applications

Erasmus MC - Sophia Children’s Hospital
2023-2025

Erasmus MC
2023-2025

University Medical Center
2024

Erasmus MC Cancer Institute
2024

Erasmus University Rotterdam
2023

Data on the use of mechanical circulatory support devices in pregnant women are limited. A 27-year-old woman at 27 weeks and 6 days gestation was supported by three different due to cardiogenic shock. She came into spontaneous labor, which complicated major hemorrhage cannulation site, fetal distress, transverse position, requiring emergency cesarean section. The postpartum period intra-abdominal bleeding arterial occlusion lower extremity. When using women, a multidisciplinary approach is...

10.37349/ec.2025.101244 article EN cc-by 2025-01-14

Pregnancy in women with a prosthetic heart valve is considered high risk, primarily due to the need for effective anticoagulation. However, data on relationship between anticoagulation practices and pregnancy outcomes are very limited. The Registry of Cardiac disease global registry that prospectively enrolled pregnancies January 2018 April 2023. Detailed anticoagulation, including dosage monitoring, cardiovascular, pregnancy, perinatal were collected. In total, 613 included which 411...

10.1093/eurheartj/ehaf265 article EN PubMed 2025-04-16

Abstract Introduction Recurrent postmenopausal bleeding (PMB) occurs in 6%–25% of women who have experienced a previous episode PMB. The question whether recurrent PMB leads to higher risk endometrial cancer (EC) comparison single is, however, controversial. Furthermore, little is known about predictive factors for Material and Methods A multicenter prospective cohort study was conducted over 5‐year period four hospitals the Netherlands. Women with undergoing sampling aged 40 years older...

10.1111/aogs.14851 article EN cc-by-nc Acta Obstetricia Et Gynecologica Scandinavica 2024-05-02

Graphical AbstractIdentification of knowledge gaps in pregnant women with aortic pathology or a genetic predisposition to develop pathology.Open new tabDownload slide

10.1093/eurheartj/ehae697 article EN other-oa European Heart Journal 2024-11-28

Abstract Aims Data on diuretic use in pregnancy are limited and inconsistent, consequently it remains unclear whether they can be used safely. Our study aims to evaluate the perinatal outcomes after in‐utero exposure. Methods results The Registry Of Pregnancy And Cardiac disease (ROPAC) is a prospective, global registry of pregnancies women with heart disease. Outcomes were compared between who diuretics during versus those did not. Multivariable regression analysis was assess impact...

10.1002/ejhf.3301 article EN cc-by-nc European Journal of Heart Failure 2024-06-04

*No data available on delivery, foetal and neonatal outcomes in the CARPREG II study. CARPREG, Cardiac disease Pregnancy registry; LMIC, low-and-middle-income country; M-PAC, Madras medical college And mWHO, modified World Health Organization; ROPAC, Registry of disease.

10.1093/eurheartj/ehad035 article EN cc-by-nc European Heart Journal 2023-02-07

<h3>Introduction</h3> Sustained fetal tachycardia often requires transplacental antiarrhythmic therapy. Little is known about the dose-concentration-effect correlation in mother, fetus, and newborn. Our aim was to evaluate relationship between perinatal digoxin flecainide therapy, measured maternal umbilical concentrations, effect. <h3>Methodology</h3> We conducted a retrospective case series including all pregnant women with their fetuses treated for period from January 2017 until February...

10.1136/bmjpo-2024-esdppp.43 article EN other-oa 2024-07-31

To assess the long-term quality of life (QoL) after obstetric Intensive Care Unit (ICU) admission.Cross-sectional survey study.Tertiary care centre.Women admitted to level 3 ICU during pregnancy or ≤6 weeks postpartum, between 2000 and 2015.Quality measures were compared with population reference values. Associations baseline parameters assessed multivariable linear regression. Patient-reported outcome experience (PROMs/PREMs) described.Quality according Linear Analogous Scale (LAS),...

10.1111/1471-0528.17400 article EN cc-by-nc BJOG An International Journal of Obstetrics & Gynaecology 2023-01-19

( BJOG . 2024;130(7):813–822) Women admitted to the intensive care unit (ICU) during pregnancy or postpartum have altered their physical and psychological quality of life (QoL). Maternal perinatal mortality morbidity are distressing issues impacting many facilities. The long-term impact peripartum ICU admission is unknown. Two prior studies on QoL after obstetric admissions found it important record emotional patient family.

10.1097/01.aoa.0001005216.45953.a7 article EN Obstetric Anesthesia Digest 2024-02-22

Abstract Background Mothers requiring the antiarrhythmic agent flecainide are often advised not to breastfeed, because of lack data concercing neonatal effects and plasma concentrations following maternal exposure as well via lactation. This is first report on combined maternal, fetal, breastmilk in a breastfed infant mother treatment. Case presentation A 35-year old Gravida 2 Para 1, known with ventricular arrhythmia, was referred our tertiary center at 35 + 4 weeks gestation. Because an...

10.1186/s13006-023-00559-z article EN cc-by International Breastfeeding Journal 2023-04-14

Abstract Background: Mothers requiring the antiarrhythmic agent flecainide are often advised not to breastfeed, because of lack data concercing neonatal effects and plasma concentrations following maternal exposure as well via lactation. This is first report on combined maternal, fetal, breastmilk in a breastfed infant mother treatment. Case presentation: All fell within therapeutic range. The fetal ratio was 0.72 milk 2.5. relative dose received compared 5.6%. Neonatal were detectable,...

10.21203/rs.3.rs-2498921/v1 preprint EN cc-by Research Square (Research Square) 2023-01-24

Objective Ebstein’s anomaly is a rare congenital cardiac condition and data regarding pregnancy outcomes in this patient group are scarce. We evaluated the maternal perinatal risks of 81 women with anomaly. Methods The Registry Pregnancy Cardiac disease prospective global registry pregnancies structural disease. were examined. primary outcome was occurrence major adverse event (MACE) defined as mortality, heart failure, arrhythmia, thromboembolic or endocarditis. Secondary endpoints...

10.1136/openhrt-2023-002406 article EN cc-by-nc Open Heart 2023-08-01
Coming Soon ...